Evidence map›Paper›PMID 27159086›Full record

ArticleNature methods2016

A hybrid approach for de novo human genome sequence assembly and phasing.

Yulia Mostovoy, Michal Levy-Sakin, Jessica Lam, Ernest T Lam, Alex R Hastie, Patrick Marks, Joyce Lee, Catherine Chu, Chin Lin, Željko Džakula and 6 more

Abstract read
In one paragraph

Article in Nature methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A gapless genome assembly of aFrontiers in plant science · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yulia MostovoyCardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Michal Levy-SakinCardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Jessica LamCardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Ernest T LamBioNano Genomics, Inc., San Diego, California, USA.
Alex R HastieBioNano Genomics, Inc., San Diego, California, USA.
Patrick Marks10X Genomics, Inc., Pleasanton, California, USA.
Joyce LeeBioNano Genomics, Inc., San Diego, California, USA.
Catherine ChuCardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Chin LinCardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Željko DžakulaBioNano Genomics, Inc., San Diego, California, USA.
Han CaoBioNano Genomics, Inc., San Diego, California, USA.
Stephen A SchlebuschDepartment of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.
Kristina Giorda10X Genomics, Inc., Pleasanton, California, USA.
Michael Schnall-Levin10X Genomics, Inc., Pleasanton, California, USA.
Jeffrey D WallInstitute for Human Genetics, University of California, San Francisco, San Francisco, California, USA.
Pui-Yan KwokCardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.

Funding

Single molecule DNA mapping for genome and CNV analysisR01HG005946 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KWOK, PUI-YAN, XIAO, MING · 2010 to 2021
$6.5M
Estimating fine scale changes in recombination rates across speciesR01GM115433 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WALL, JEFFREY D · 2015 to 2018
$1.2M
NHGRI NIH HHS R01 HG005946NIGMS NIH HHS R01 GM115433
6 · The paper itself

Abstract

Despite tremendous progress in genome sequencing, the basic goal of producing a phased (haplotype-resolved) genome sequence with end-to-end contiguity for each chromosome at reasonable cost and effort is still unrealized. In this study, we describe an approach to performing de novo genome assembly and experimental phasing by integrating the data from Illumina short-read sequencing, 10X Genomics linked-read sequencing, and BioNano Genomics genome mapping to yield a high-quality, phased, de novo assembled human genome.

Indexed as

Genome, HumanChromosome MappingGenomicsHaplotypesHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID27159086
PMCPMC4927370

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.